Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Computational Chemistry
|
April 8, 2015
Using bonding to guide transition state optimization
Adam B Birkholz, H Bernhard Schlegel
The Journal of Chemical Physics
|
January 3, 2016
Path optimization by a variational reaction coordinate method. I. Development of formalism and algorithms
Adam B Birkholz, H Bernhard Schlegel
The Journal of Chemical Physics
|
May 16, 2016
Path optimization by a variational reaction coordinate method. II. Improved computational efficiency through internal coordinates and surface interpolation
Adam B Birkholz, H Bernhard Schlegel
Organic Letters
|
December 21, 2019
Mechanistic Insights into the Racemization of Fused Cyclopropyl Isoxazolines
Kyle W Quasdorf, Adam B Birkholz, Michael D Bartberger, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Computational Chemistry
|
April 8, 2015
Using bonding to guide transition state optimization
Adam B Birkholz, H Bernhard Schlegel
The Journal of Chemical Physics
|
January 3, 2016
Path optimization by a variational reaction coordinate method. I. Development of formalism and algorithms
Adam B Birkholz, H Bernhard Schlegel
The Journal of Chemical Physics
|
May 16, 2016
Path optimization by a variational reaction coordinate method. II. Improved computational efficiency through internal coordinates and surface interpolation
Adam B Birkholz, H Bernhard Schlegel
Organic Letters
|
December 21, 2019
Mechanistic Insights into the Racemization of Fused Cyclopropyl Isoxazolines
Kyle W Quasdorf, Adam B Birkholz, Michael D Bartberger, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Page
of 1